NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
-10.18%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.15B
AUM Growth
+$1.15B
(-20%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
45.41%
Holding
128
New
10
Increased
29
Reduced
51
Closed
11
Top Buys
| 1 |
Costco
COST
|
$34.3M |
| 2 |
RH
RH
|
$19.1M |
| 3 |
Peloton Interactive
PTON
|
$17.1M |
| 4 |
Lyra Therapeutics
LYRA
|
$13.4M |
| 5 |
MediaAlpha
MAX
|
$11.9M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$58.3M |
| 2 |
International Money Express
IMXI
|
$29.4M |
| 3 |
FTVI
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
|
$9.82M |
| 4 |
FTCV
FinTech Acquisition Corp. V Class A Common Stock
FTCV
|
$9.46M |
| 5 |
HCA Healthcare
HCA
|
$8.92M |
Sector Composition
| 1 | Healthcare | 41.8% |
| 2 | Consumer Discretionary | 22.1% |
| 3 | Industrials | 9.23% |
| 4 | Financials | 7.04% |
| 5 | Communication Services | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
APEN
26
DELISTED
Apollo Endosurgery, Inc.
APEN
| $13.6M | 0.68% | 3,723,010 -1,889 | -0.1% | -$6.9K |
|
|
27
Lyra Therapeutics
LYRA
$11.5M
| $13.4M | 0.67% | +2,369,668 | New | +$13.4M |
|
28
Reading International Class A
RDI
$35M
| $11.6M | 0.58% | 3,207,247 -19,409 | -0.6% | -$70.1K |
|
|
AMYT
29
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $10.9M | 0.55% | 1,562,458 +490,922 | +46% | +$3.43M |
|
30
DarioHealth
DRIO
$22.8M
| $10.6M | 0.53% | 1,730,810 +14,803 | +0.9% | +$90.9K |
|
|
BBQ
31
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $9.88M | 0.5% | 948,254 -3,305 | -0.3% | -$34.4K |
|
32
Semler Scientific
SMLR
$439M
| $9.77M | 0.49% | 346,606 -10,269 | -3% | -$289K |
|
|
IIII
33
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
| $9.66M | 0.48% | 980,183 -14,990 | -2% | -$148K |
|
34
Viemed Healthcare
VMD
$286M
| $9.23M | 0.46% | 1,714,926 +421,114 | +33% | +$2.27M |
|
|
ARYE
35
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
| $8.38M | 0.42% | 862,566 -3,067 | -0.4% | -$29.8K |
|
36
RingCentral
RNG
$2.76B
| $7.84M | 0.39% | +150,000 | New | +$7.84M |
|
|
CBAY
37
DELISTED
Cymabay Therapeutics
CBAY
| $7.8M | 0.39% | 2,644,306 +750,309 | +40% | +$2.21M |
|
|
HERA
38
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $7.71M | 0.39% | 787,130 -12,871 | -2% | -$126K |
|
39
Fortress Biotech
FBIO
$76.8M
| $7.36M | 0.37% | 8,758,648 -83,877 | -0.9% | -$70.4K |
|
|
CNCE
40
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.99M | 0.35% | +1,659,840 | New | +$6.99M |
|
41
Scully Royalty
SRL
$78.3M
| $6.19M | 0.31% | 771,196 -1,241 | -0.2% | -$9.96K |
|
42
Taysha Gene Therapies
TSHA
$797M
| $6.11M | 0.31% | 1,643,438 +309,491 | +23% | +$1.15M |
|
43
ARS Pharmaceuticals
SPRY
$1.15B
| $5.88M | 0.29% | 1,386,138 +472,541 | +52% | +$2M |
|
44
ON24
ONTF
$242M
| $5.41M | 0.27% | 570,403 +186,315 | +49% | +$1.77M |
|
|
APTO
45
DELISTED
Aptose Biosciences, Inc.
APTO
| $5.37M | 0.27% | 7,232,676 -89,513 | -1% | -$66.4K |
|
46
Gyre Therapeutics
GYRE
$703M
| $4.91M | 0.25% | 2,755,903 +335,114 | +14% | +$597K |
|
47
Aura Biosciences
AURA
$389M
| $4.86M | 0.24% | 343,215 +41,225 | +14% | +$584K |
|
48
Stryker
SYK
$150B
| $4.58M | 0.23% | +23,000 | New | +$4.58M |
|
49
Strata Skin Sciences
SSKN
$9.93M
| $4.4M | 0.22% | 4,575,812 | – | – |
|
|
50
iShares Russell 2000 ETF
IWM
$67B
| $4.04M | 0.2% | 23,873 -344,156 | -94% | -$58.3M |
|